ID Q2XQV0_MOUSE Unreviewed; 279 AA.
AC Q2XQV0;
DT 20-DEC-2005, integrated into UniProtKB/TrEMBL.
DT 20-DEC-2005, sequence version 1.
DT 27-MAR-2024, entry version 107.
DE SubName: Full=Perlecan {ECO:0000313|EMBL:ABB73040.1};
DE Flags: Fragment;
GN Name=Hspg2 {ECO:0000313|MGI:MGI:96257};
OS Mus musculus (Mouse).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC Murinae; Mus; Mus.
OX NCBI_TaxID=10090 {ECO:0000313|EMBL:ABB73040.1};
RN [1] {ECO:0000313|EMBL:ABB73040.1}
RP NUCLEOTIDE SEQUENCE.
RC STRAIN=C57BL {ECO:0000313|EMBL:ABB73040.1};
RC TISSUE=Liver {ECO:0000313|EMBL:ABB73040.1};
RX PubMed=16804890; DOI=10.1002/dvdy.20888;
RA Muriel J.M., Xu X., Kramer J.M., Vogel B.E.;
RT "Selective assembly of fibulin-1 splice variants reveals distinct
RT extracellular matrix networks and novel functions for perlecan/UNC-52
RT splice variants.";
RL Dev. Dyn. 235:2632-2640(2006).
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; DQ266428; ABB73040.1; -; mRNA.
DR RefSeq; NP_032331.2; NM_008305.3.
DR AlphaFoldDB; Q2XQV0; -.
DR PeptideAtlas; Q2XQV0; -.
DR GeneID; 15530; -.
DR KEGG; mmu:15530; -.
DR AGR; MGI:96257; -.
DR CTD; 3339; -.
DR MGI; MGI:96257; Hspg2.
DR OrthoDB; 2877710at2759; -.
DR BioGRID-ORCS; 15530; 3 hits in 79 CRISPR screens.
DR ChiTaRS; Hspg2; mouse.
DR Genevisible; Q2XQV0; MM.
DR CDD; cd00096; Ig; 1.
DR Gene3D; 2.60.40.10; Immunoglobulins; 4.
DR InterPro; IPR007110; Ig-like_dom.
DR InterPro; IPR036179; Ig-like_dom_sf.
DR InterPro; IPR013783; Ig-like_fold.
DR InterPro; IPR003599; Ig_sub.
DR InterPro; IPR003598; Ig_sub2.
DR PANTHER; PTHR45080; CONTACTIN 5; 1.
DR PANTHER; PTHR45080:SF32; MYOTILIN; 1.
DR Pfam; PF13927; Ig_3; 2.
DR SMART; SM00409; IG; 2.
DR SMART; SM00408; IGc2; 2.
DR SUPFAM; SSF48726; Immunoglobulin; 4.
DR PROSITE; PS50835; IG_LIKE; 4.
PE 2: Evidence at transcript level;
FT DOMAIN 1..35
FT /note="Ig-like"
FT /evidence="ECO:0000259|PROSITE:PS50835"
FT DOMAIN 42..132
FT /note="Ig-like"
FT /evidence="ECO:0000259|PROSITE:PS50835"
FT DOMAIN 142..228
FT /note="Ig-like"
FT /evidence="ECO:0000259|PROSITE:PS50835"
FT DOMAIN 242..279
FT /note="Ig-like"
FT /evidence="ECO:0000259|PROSITE:PS50835"
FT REGION 137..157
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 230..252
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT NON_TER 1
FT /evidence="ECO:0000313|EMBL:ABB73040.1"
FT NON_TER 279
FT /evidence="ECO:0000313|EMBL:ABB73040.1"
SQ SEQUENCE 279 AA; 29846 MW; 127508785C4B5AAE CRC64;
GSRLRLLQVT PTDSGEYVCR VVSGSGTQEA SILVTIQQTL SPSHSQSVVH PVRIESSSPS
LANGHTLDLN CLVASLTPHT ITWYKRGGSL PSRHQIVGSR LRIPQVTPAD SGEYVCHVSN
GAGSQETSLI VTIESRGPSH VPSVSPPMRI ETSSPTVTEG QTLDLNCVVV GRPQATITWY
KRGGSLPFRH QAHGSRLRLH HMSVADSGEY VCRANNNIDA QETSIMISVS PSTNSPPAPA
SPAPIRIESS SSRVAEGQTL DLNCVVPGHA HAQVTWHKR
//